1. MALT Lymphomas: A radiation oncology viewpoint

   • Joachim Yahalom

   Selected Papers Pages: B100 - B105

2. Indications for early autologous stem cell transplantation in aggressive lymphoma

   • Hanneke C. Kluin-Nelemans

   Selected Papers Pages: B121 - B122

3. The future of monoclonal antibody engineering

   • Christoph Renner
   • Frank Hartmann
   • Michael Pfreundschuh

   Selected Papers Pages: B127 - B129

4. High dose radioimmunotherapy in relapsed B-cell lymphoma with I-131 Rituximab

   • W. Becker
   • Th. Behr

   Selected Papers Pages: B130 - B131

5. 5. Report on Workshop: Primary CNS Lymphoma

   • A. Korfel
   • J. Finke
   • E. Thiel

   Workshop Report Pages: B20 - B23

6. Cell death in T- and B-cell development

   • Klaus-Michael Debatin

   Selected Papers Pages: B29 - B31

7. Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas

   • Swen Wessendorf
   • Peter Lichter
   • Martin Bentz

   Selected Papers Pages: B35 - B37

8. Prognostic factor in aggressive lymphoma: The contribution of novel biological markers

   • Emili Montserrat

   Selected Papers Pages: B42 - B44

9. Novel imaging techniques in NHL: Clinical results with PET imaging

   • I. Buchmann
   • S. N. Reske

   Selected Papers Pages: B54 - B57

10. Mediastinal B-cell lymphoma, a lymphoma type with several characteristics unique among diffuse large B-cell lymphomas

    • Thomas F. E. Barth
    • Frank Leithäuser
    • Peter Möller

    Selected Papers Pages: B49 - B53

11. Follicular non-Hodgkin's lymphoma: the role of radiation therapy

    • Peter Mauch

    Selected Papers Pages: B63 - B65

12. Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy

    • J. Grenzebach
    • M. Schrappe
    • on behalf of the BFM-Group

    Selected Papers Pages: B73 - B76

13. 2. Report on the Workshop: “Clinical Consequences of Pathology and Prognostic Factors in Aggressive NHL”

    • Markus Loeffler
    • Margaret Shipp
    • Harald Stein

    Workshop Report Pages: B8 - B12

14. Modelling of chemotherapy: The effective dose approach

    • Dirk Hasenclever
    • Oana Brosteanu
    • Markus Loeffler

    Selected Papers Pages: B89 - B94

15. Treatment Strategies in Elderly Patients with Aggressive Histology Lymphoma

    • C. Tom Kouroukis
    • Ralph M. Meyer

    Selected Papers Pages: B86 - B88

16. Helicobacter pylori eradication therapy in gastric high grade Hon Hodgkin's lymphoma (NHL)

    • Birgit Alpen
    • Julia Röbbecke
    • Andreas Neubauer

    Selected Papers Pages: B106 - B107

17. Lymphoma 2000

    • Michael Pfreundschuh

    Introduction Pages: B1 - B2

18. Therapeutic management of refractory or relapsed primary central nervous system lymphomas

    • Michele Reni
    • Andrés José María Ferreri

    Selected Papers Pages: B113 - B118

19. High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments

    • Corrado Tarella
    • Alessandra Cuttica
    • Alessandro Pileri

    Selected Papers Pages: B123 - B126

20. 3. Report on Workshop: UICC Workshop “Therapy of NHL in early stages”

    • Marianne Engelhard
    • Martin Stuschke

    Workshop Report Pages: B13 - B15

21. 4. Report on Workshop: UICC Workshop “Therapy of NHL in early stages”

    • Rudolf Schmits
    • Lorenz Trümper

    Workshop Report Pages: B16 - B19

22. New strategies for vaccination and imunomodulation in NHL

    • Freda K. Stevenson
    • Delin Zhu
    • Jason Rice

    Selected Papers Pages: B132 - B134

23. 6. Report on Workshop: EBMT Workshop “High dose therapy in aggressive NHL”

    • Norbert Schmitz

    Workshop Report Pages: B24 - B26

24. Cytogenetic subtyping of diffuse large B-cell lymphomas

    • Brigitte Schlegelberger

    Selected Papers Pages: B32 - B34

25. Gene expression analysis in aggressive NHL

    • W. C. Chan
    • J. Z. Huang

    Selected Papers Pages: B38 - B41

26. Workshop Report: “Genetics and Immunology of aggressive NHL”

    • Martin Bentz
    • Lorenz Trümper

    Workshop Report Pages: B5 - B7

27. Therapeutic consequences of pathology and prognostic factors in aggressive NHL – Analysis of ALCL

    • R. D. Gascoyne

    Selected Papers Pages: B45 - B48

28. Five theses concerning the clinical consequences of pathology and prognostic factors

    • Dirk Hasenclever
    • Markus Loeffler

    Selected Papers Pages: B58 - B60

29. Management of localized (stage I and II) clinically aggressive lymphomas

    • R. W. Tsang
    • M. K. Gospodarowicz

    Selected Papers Pages: B66 - B72

30. Therapeutic strategies for agressive lymphomas: The trials of the DSHNHL

    • Rudolf Schmits
    • Bertram Glass
    • for the German High-Grade Non-Hodgkin's Lymphoma Study Group

    Selected Papers Pages: B77 - B83

31. Consolidation radiotherapy to bulky disease in aggressive NHL. First results of the NHL B-94 trial of the DSHNHL

    • Christian Rübe
    • T. Phu Nguyen
    • Michael Pfreundschuh

    Selected Papers Pages: B84 - B85

32. Radiotherapy in early stage gastrointestinal lymphoma: Results of the German GIT-NHL group

    • Normann A. Willich
    • Gabriele Reinartz
    • for the German Gastrointestinal lymphoma group

    Selected Papers Pages: B97 - B99

33. Therapy of PCNSL at the Massachusetts General Hospital with high dose methotrexate and deferred radiotherapy

    • F. H. Hochberg
    • G. Tabatabai

    Selected Papers Pages: B111 - B112

34. Abstracts

    Pages: B137 - B163